The effects of interfacial interactions, packed and dispersed microspheres, and the topography of crystallization vessels are explored in the crystal growth of two polymorphic pharmaceutical drugs; carbamazepine and theophylline. Three distinct results have emerged from this work: (1) Thiol self-assembled monolayers (SAMs) bearing carboxy functionalities at the interface selectively nucleate the (011) face of the P-monoclinic form of carbamazepine. Geometrical and chemical complementarities at the interface are analyzed to establish the epitaxial relationship between the SAM surface and the crystal faces. (2) Glass vials coated with perfluorinated (PF) silane SAMs led to larger, better formed crystals due to reduced interfacial interactions...
Studies on the use of template surfaces to induce heterogeneous crystal nucleation have gained momen...
NoSpherical crystallization involves crystallization and simultaneous agglomeration of a crystalline...
Polymorphism in pharmaceutical drug crystals causes differences in their bioavailability, stability ...
Surface-induced nucleation of carbamazepine (CBZ) in ethanol was investigated with different surface...
Surface-induced nucleation of carbamazepine (CBZ) in ethanol was investigated with different surface...
Directed crystal growth often requires considerable experimental effort to achieve epitaxial control...
Directed crystal growth often requires considerable experimental effort to achieve epitaxial control...
The objective of this research was to characterize the intermolecular interactions between additives...
Controlling pharmaceutical polymorphism in crystallization processes represents a major challenge in...
Polymorphism, the phenomenon in which a compound crystallizes into more than one solid state crystal...
Controlling pharmaceutical polymorphism in crystallization processes represents a major challenge in...
Intermolecular interactions between additives and drug molecules that lead to changes in nucleation ...
The objective of this research was to study the effects of polymers on the crystallization of specif...
Intermolecular interactions between additives and drug molecules that lead to changes in nucleation ...
The objective of this research was to study the effects of polymers on the crystallization of specif...
Studies on the use of template surfaces to induce heterogeneous crystal nucleation have gained momen...
NoSpherical crystallization involves crystallization and simultaneous agglomeration of a crystalline...
Polymorphism in pharmaceutical drug crystals causes differences in their bioavailability, stability ...
Surface-induced nucleation of carbamazepine (CBZ) in ethanol was investigated with different surface...
Surface-induced nucleation of carbamazepine (CBZ) in ethanol was investigated with different surface...
Directed crystal growth often requires considerable experimental effort to achieve epitaxial control...
Directed crystal growth often requires considerable experimental effort to achieve epitaxial control...
The objective of this research was to characterize the intermolecular interactions between additives...
Controlling pharmaceutical polymorphism in crystallization processes represents a major challenge in...
Polymorphism, the phenomenon in which a compound crystallizes into more than one solid state crystal...
Controlling pharmaceutical polymorphism in crystallization processes represents a major challenge in...
Intermolecular interactions between additives and drug molecules that lead to changes in nucleation ...
The objective of this research was to study the effects of polymers on the crystallization of specif...
Intermolecular interactions between additives and drug molecules that lead to changes in nucleation ...
The objective of this research was to study the effects of polymers on the crystallization of specif...
Studies on the use of template surfaces to induce heterogeneous crystal nucleation have gained momen...
NoSpherical crystallization involves crystallization and simultaneous agglomeration of a crystalline...
Polymorphism in pharmaceutical drug crystals causes differences in their bioavailability, stability ...